Anticoagulant-Related Bleeding:Clinical Epidemiology, Prediction, and Prevention
Am J Med 95:315-328, Landefeld,C.S.&Beyth,R.J., 1993
Cost Effectiveness of Primary Stroke Prevention in Atrial Fibrillation
BMJ 305:1457-1460, 14451992., Gustafsson,C.,et al, 1992
Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
NEJM 327:1406-1412, 14511992., Ezekowitz,M.D.,et al, 1992
Failure of High-Dose Heparin to Prevent Recurr Cardioembolic Strokes in Preg Pt with Mech Heart Valve
Neurol 42:2204-2206, Golby,A.J.,et al, 1992
Tardive Dyskinesia Associated with Use of Metoclopramide in a Child
J Pediatr 121:983-985, Putnam,P.E.,et al, 1992
Cortical Blindness after Nifedipine Treatment
BMJ 305:693, Morton,C.&Hickey-Dwyer,M., 1992
Acute Compartment Syndromes Resulting from Anticoagulant Treatment
BMJ 305:1474-1475, Hay,S.M.,et al, 1992
'De Novo'Absence Status of Late Onset:Report of 11 Cases
Neurol 42:104-110, Thomas,P.,et al, 1992
Clinical Trial of Nimodipine in Acute Ischemic Stroke
The American Nimodipine Study Group, Stroke 23:3-81992., , 1992
Subarachnoid Haemorrhage
Lancet 339:653-655, Van Gijn,J., 1992
Do NMDA Antagonists Prevent Neuronal Injury? Yes
ARch Neurol 49:418-420, Albers,G.W.,et al, 1992
Do NMDA Antagonists Prevent Neuronal Injury? No
Arch Neurol 49:420-421, Buchan,A.M., 1992
Valve Disease Associated with Ergot Alkaloid Use:Echocardiographic and Pathologic Correlations
Ann Int Med 117:50-52, Redfield,M.M.,et al, 1992
Atenolol Compared with Nifedipine:Effect on Cognitive Function and Mood in Elderly Hypertensive Patients
Ann Int Med 116:615-623, Skinner,M.H.,et al, 1992
Cluster Headache
Neurol 42 (Suppl 2) :22-31992., Mathew,N.T., 1992
Pharmacologic Treatment of Childhood Migraine
J Pediatr 120:653-657, Ingarashi,M.,et al, 1992
Emergency Treatment of Headache
Neurol 42 (Suppl 2) :43-44992., Rapoport,A.M.&Silberstein,S.D., 1992
Treatment of Migraine
Lancet 339:1207-1209, Lance,J.W., 1992
Elevated Carbamazepine Levels Associated with Diltiazem Use
Neurol 42:937-938, Shaughnessy,A.F.&Mosley,M.R., 1992
Drug-Induced Movement Disorders:An Overview
In Movement Dis in Neurol & Neuropsych, Blackwell Sci Publ, Boston, 2:21., Miller,L.G.&Jankovic,J., 1992
Extrapyramidal side Effects of Antiemetics Presenting as Psychiatric Illness
Gen Hosp Psychiatry 14:192-195, Rodgers,C., 1992
The Use of Sedative Agents in Critically Ill Patients
Drugs 43:507-515, Burns,A.M.,et al, 1992
Antithrombotic Therapy in Cerebrovascular Disease
Ann Int Med 115:885-895, Rothrock,J.F.&Hart,R.G., 1991
Stroke Prevention in Nonvalvular Atrial Fibrillation:A Review of Prospective Randomized Trials
Ann Neurol 30:511-518, Albers,G.W.,et al, 1991
Influence of Low-Intensity Warfarin Treatment of Patients'Perceptions of Quality of Life
Editorial, Arch Int Med 151:1921-1922, 1944-1949991., , 1991
Stroke Prevention in Nonvalvular Atrial Fibrillation
Ann Int Med 115:727-736, Albers,G.W.,et al, 1991
Physicians'Attitudes Toward Anticoag & Antiplat Agents for Stroke Prevent in Elderly Pts with Atrial Fib
Arch Int Med 151:1950-1953, 19221991., Kutner,M.,et al, 1991
Tissue Plasminogen Activator Plus Glutamate Antagonist Improves Outcome after Embolic Stroke
Arch Neurol 48:1235-1238, Zivin,J.A.&Mazzarella,V., 1991
The Bioloigcal Basis for the Treatment of Acute Stroke
Neurol 41:1867-1873, Scheinberg,P., 1991
A Reduction in Verapamil Concentrations with Phenytoin
NEJM 325:1179, Woodcock,B.G.,et al, 1991
The Effect of Flunarizine on Essential Tremor
Neurol 41:311-312, Biary,N.,et al, 1991
A Randomized Clinical Study of a Calcium-Entry Blocker (Lidoflzaine) in the Treatment of Comatose Survivors of Cardiac Arrest
NEJM 324:1225-1231, 1278-12801991., , 1991
Recurrent Attacks of Amaurosis Fugax Treated with Calcium Channel Blocker
Ann Neurol 30:423-425, Winterkorn,J.M.S.&Teman,A.J., 1991
Next-Day Memory Impairment with Triazolam Use
Lancet 337:827-831, Bixler,E.O.,et al, 1991
Early Treatment of Ischemic Stroke with a Calcium Antagonist
Stroke 22:437-441, Rosenbaum,D.,et al, 1991
Atrial Fibrillation as an Independent Risk Factor for Stroke:The Framingham Study
Stroke 22:983-988, Wolf,P.A.,et al, 1991
Oral Anticoagulant Drugs
NEJM 324:1865-1875, Hirsh,J., 1991
N-Methyl-D-Aspartate Antagonists in the Treatment of Parkinson's Disease
Arch Neurol 48:977-981, Greenamyre,J.T.&O'Brien,C.F., 1991
Interactions Between Calcium Channel Blockers and the Anticonvulsants Carbamazepine and Phenytoin
Neurol 41:740-742, Bahls,F.H.,et al, 1991
Diagnosis and Treatment of Ischemic Stroke
JAMA 266:2413-2418, Caplan,L.R., 1991
Syncope and Presyncope Associated with Probable Adverse Drug Reactions
Arch Int Med 150:2309-2312, Hanlon,J.T.,et al, 1990
Advances in Cluster Headache
Neurologic Clinics, 8:867-8901990., Mathew,N.T., 1990
Calcium Antagonists:Stroke Therapy Coming of Age
Stroke 21:494-501, Wong,M.C.W.&Haley,E.C., 1990
Thromboembolic Complications in Atrial Fibrillation
Stroke 21:4-13, Petersen,P., 1990
Preliminary Report of the Stroke Prevention in Atrial Fibrillation Study
Study Group, NEJM 322:863-8681990., , 1990
Nifedipine for Intractable Hiccups
Neurol 40:531-532, Lipps,D.C.,et al, 1990
The Effect of Warfarin on Mortality and Reinfarction after Myocardial Infarction
NEJM 323:148-152, Smith,P.,et al, 1990
Anticoagulation:Is There Still a Role in Atherothrombotic Stroke
Stroke 21:820-824, Estol,C.J.&Pessin,M.S., 1990
"Endogenous"Benzodiazepine Activity in Body Fluids of Patients with Hepatic Encephalopathy
Lancet 336:81-83, Mullen,K.D.,et al, 1990
Risks Associated with Giving Benzodiazepines to Patients with Acute Neurological Injuries
BMJ 300:1189-1190, Eldridge,P.R.&Punt,J.A.G., 1990